Final results of a phase II study of oral vinorelbine (NVBo) monotherapy in patients (pts) with advanced EGFR-positive non-small-cell lung cancer (NSCLC) after failure of EGFR-TKI in first line (NAVoTRIAL 2)
2016 ◽
Vol 27
◽
pp. vi446
E.-H. Tan
◽
G. Banna
◽
R. Ramlau
◽
G. Ceresoli
◽
A. Camerini
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. e20546-e20546
Eng-Huat Tan
◽
Giuseppe Luigi Banna
◽
Rodryg Ramlau
◽
Giovanni Luca Ceresoli
◽
Andrea Camerini
◽
...
2015 ◽
Vol 51
◽
pp. S615-S616
E.H. Tan
◽
G. Banna
◽
R. Ramlau
◽
G.L. Ceresoli
◽
A. Camerini
◽
...
2003 ◽
Vol 39
(1)
◽
pp. 77-84
◽
J.M Vieitez
◽
M Valladares
◽
M Gracia
◽
M Gonzalez-Barón
◽
G Martı́n
◽
...
2012 ◽
Vol 23
◽
pp. ix408
C. Twelves
◽
E. Chmielowska
◽
L. Havel
◽
S. Popat
◽
A. Swieboda-Sadlej
◽
...
M. Tamiya
◽
A. Tamiya
◽
H. Kaneda
◽
K. Nakagawa
◽
K. Goto
◽
...
2006 ◽
Vol 61
(2)
◽
pp. 143
Ki Eun Hwang
◽
So Young Kim
◽
Jong Hoon Jung
◽
Seong Hoon Park
◽
Jung Hyun Park
◽
...
2007 ◽
Vol 2007
◽
pp. 195-197
1995 ◽
Vol 13
(1)
◽
pp. 96-97
2012 ◽
Vol 23
◽
pp. ix409
E.H. Tan
◽
L. Havel
◽
M.J. Krzakowski
◽
J. Kollmeier
◽
R. Gervais
◽
...
Alessandro Passardi
◽
Lorenzo Cecconetto
◽
Monia Dall'Agata
◽
Claudio Dazzi
◽
Enzo Pasquini
◽
...
Close
Export Citation Format
Close
Share Document
Close